Table 1 Regimens of Option A, Option B and Option B+ recommended by WHO
Option B | Option B+ | |
|---|---|---|
Mother | women received ART during pregnancy if eligible by either CD4 or clinical criteria. Women not eligible for ART were modelled to receive triple-antiretroviral prophylaxis of zidovudine, lamivudine and lopinavir and ritonavir (AZT* + 3TC* + LPV/r*) or zidovudine, lamivudine and efavirenz (AZT + 3TC + EFV*) from 14 weeks until 42 days after delivery | all women received lifelong ART |
Infant | Daily NVP* or twice daily AZT from birth until 42 days of age | Daily NVP or twice daily AZT from birth until 42 days of age |